<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
56125-800-01
</NDCCode>
<PackageDescription>
66.7 kg in 1 CAN (56125-800-01)
</PackageDescription>
<NDC11Code>
56125-0800-01
</NDC11Code>
<ProductNDC>
56125-800
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Sirolimus
</NonProprietaryName>
<DosageFormName>
SUSPENSION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20000825
</StartMarketingDate>
<EndMarketingDate>
20281001
</EndMarketingDate>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Novo Nordisk Production Ireland Limited
</LabelerName>
<SubstanceName>
SIROLIMUS
</SubstanceName>
<StrengthNumber>
150
</StrengthNumber>
<StrengthUnit>
g/kg
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-01-27
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
25-AUG-00
</StartMarketingDatePackage>
<EndMarketingDatePackage>
01-OCT-28
</EndMarketingDatePackage>
<SamplePackage/>
</NDC>